Researchers investigate the need for prioritizing COVID-19 booster vaccination.
New collaboration aims to break through LGMD treatment barriers
Critical Path Institute (C-Path) today announced the formation of a new task force under its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), dedicated to